International Conference on Gastroenterology and Chronic Liver Diseases ICGCLD | 27

About the event

• Chronic Liver Disease Management: Latest pharmacologic developments, therapeutic pathways, and lifestyle intervention protocols designed to alter disease progression. • Cirrhosis Pathophysiology: Underlying cellular mechanisms, clinical implications, and modern approaches to managing advanced cirrhosis. • Fibrosis Assessment and Monitoring: Non-invasive and clinical strategies for tracking, measuring, and staging liver fibrosis. • Non-Alcoholic Fatty Liver Disease (NAFLD/NASH): Current clinical perspectives, risk evaluation models, and metabolic integration strategies. • Hepatitis Innovations: Emerging therapeutic options and long-term care management for chronic viral and autoimmune hepatitis. • Lifestyle & Comorbid Interventions: The impact of lifestyle modifications, nutritional therapy, and co-occurring conditions (such as mental health and alcohol use) on overall liver resilience.